Anebulo Pharmaceuticals Announces Completion of Tender Offer, Purchases 300,000 Shares at $3.50 per Share for $1.05 Million.

Anebulo Pharmaceuticals announced the final results of its voluntary self-tender offer to purchase 300,000 shares of its common stock. A total of 4,907,881 shares were properly tendered and not withdrawn, with 300,000 shares accepted for payment at $3.50 per share for an aggregate cost of $1.05 million. The shares accepted represent approximately 0.73% of the outstanding shares as of January 26, 2026.